$SRF Hit 52 week high of Rs.1556. Had recommended at Rs.920 in Feb 2015. $ZENSARTECH Hit 52 week high of Rs.1130. Had recommended at Rs.920 in Aug 2015. These 2 stocks along with all the other stocks in my portfolio have rewarded me well.$LINCOPH , $GMBREW , $PinconSpirit , $WELSPUNIND , $BRITANNIA , $AJANTPHARM .Will recommend 2 more new bullish stocks in coming days. Just waiting for a specific market news on those stocks for confirming. For all my other stocks #bullish#buy
$BRITANNIA has hit a 52 week high of Rs.3434 today.$AJANTPHARM has hit Rs.1711 but the others $SRF$PITTILAM$WELSPUNIND and $GMBREW have fallen due to sudden China's unexpected move to weaken its currency yuan which gives them an unfair advantage in world markets. Short term looks weak and one can exit if need money urgently or else can hold as long term prospects are still good, but big falls and rises can be expected now onwards mainly due to China move resulting in currency fluctuations.
Raks 04:49 AM 06-08-2015
$SRF@Aaarti Ambani See also my not small cap recommendations even before June 11th. See my post On 29th May I said #bullish on $AJANTPHARM$BRITANNIA and $SRF. Now Ajanta Pharma 1580 - 1684 (104 increase) ,Britannia 2545 - 3228 (683 increase),SRF 1101 - 1499 (398 increase).Today is SRF results day, Iam expecting good results but even if it falls I will keep adding more of $SRF which I recommended on 16th Feb at Rs.934.
Ajanta Pharma Limited, a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products worldwide. The company provides its products in anti-malarial, cardiovascular, dermatology, male erectile dysfunction, musculoskeletal, orthopedic, gynecology, pediatric, general health, anti-biotic, respiratory, and ophthalmology therapeutic areas. The company offers its cardiovascular products for the treatment of atherothrombosis, coronary artery diseases, dyslipidemia, hypertension, and heart failure under 27 brands; dermatology products in various areas, including acne, alopecia, dermatitis/eczema, skin infections, moisturizers, pigment disorders, psoriasis, scars, and sunscreens under 48 brands; and ophthalmology products for allergies, dry eye, glaucoma, eye infections, inflammation, macular degeneration, and retinopathies under 54 brands. It also develops products for bile acid induced diseases, gastric acid-related diseases, gout, muscle relaxant, pain and inflammation, constipation, neuropathic pain, nausea and vomiting, and vertigo; and pain management products under 31 brands. The company provides its products in various dosage forms comprising tablets, capsules, powders, ophthalmic sterile eye drops, ointments, and injectables. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.